Sun Pharma shares hit 52-week high on USFDA approval for alopecia drug ...Middle East

This came after Sun Pharmaceuticals announced that the US Food and Drug Administration (USFDA) has approved its new drug application for Deuruxolitinib, a new treatment for Alopecia Areata

Hence then, the article about sun pharma shares hit 52 week high on usfda approval for alopecia drug was published today ( Friday 26/07/2024 - 09:57 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sun Pharma shares hit 52-week high on USFDA approval for alopecia drug )

Also on site :

• For the first time in 50 years, college grads are losing their edge
• Sanyou Bio's Decade: From an Intelligent Super-Trillion Antibody Library to the "Innovation Hub for Original Drug Discovery"
• Increase in revenues of Chinese public companies in 2025